MorphoSys AG buy hoffi69
Summary
This prediction ended on 28.05.14 with a price of €69.44. With a performance of 6.83%, the BUY prediction by hoffi69 for MorphoSys AG closed with a slight gain. hoffi69 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 0.300% | 0.300% | 232.093% | -0.342% |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by hoffi69 for this prediction
In the thread Morphosys AG diskutieren
Biotec top
Mit Morphosys nehme ich einen interessanten Biotech-Wert aus dem starken Tec-DAX in die Empfehlungsliste auf.Biotech mit richtig guter Rendite(!!!),da wird also schon ansehnlich Geld verdient,mit interessanten Kooperationen.Aktie mit guten Zukunftsaussichten aus einer Boom-Branche.